Cell cycle dependent regulation of deoxycytidine kinase, deoxyguanosine kinase, and cytosolic 5′-nucleotidase I activity in MOLT-4 cells

Nucleosides, Nucleotides and Nucleic Acids

Volumn 25, Issue 9-11, 2006, Pages 1201-1204

  Fyrberg, A ^a   Mirzaee, S ^b   Lotfi, K ^a,c  

^a LINKÖPING UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

5 Nucleotidase; Deoxycytidine kinase; Deoxyguanosine kinase; Nucleoside analogues

Indexed keywords

5' NUCLEOTIDASE; DEOXYCYTIDINE KINASE; DEOXYGUANOSINE KINASE; NUCLEOSIDE ANALOG;

ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; HUMAN; HUMAN CELL; T LYMPHOCYTE;

5'-NUCLEOTIDASE; CELL CYCLE; CELL LINE, TUMOR; CULTURE MEDIA, SERUM-FREE; CYTOSOL; DEOXYCYTIDINE KINASE; FLUORESCENT DYES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITORY CONCENTRATION 50; NUCLEOSIDES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS;

EID: 33750450140     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770600894386     Document Type: Article

References (10)

1. Carson, D.A.; Wasson, D.B.; Taetle, R.; Yu, A. Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes. Blood 1983, 62, 737-743.
2. Lotfi, K.; Mansson, E.; Spasokoukotskaja, T.; Pettersson, B.; Liliemark, J.; Peterson, C.; Eriksson, S.; Albertioni, F. Biochemical pharmacology and resistance to 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine, a novel analogue of cladribine in human leukemic cells. Clin. Cancer Res. 1999, 5, 2438-2444.
3. Hunsucker, S.A.; Mitchell, B.S.; Spychala, J. The 5′-nucleotidases as regulators of nucleotide and drug metabolism. Pharmacol. Ther. 2005, 107, 1-30.
4. Rylova, S.N.; Albertioni, F.; Flygh, G.; Eriksson, S. Activity profiles of deoxynucleoside kinases and 5′-nucleotidases in cultured adipocytes and myoblastic cells: insights into mitochondrial toxicity of nucleoside analogs. Biochem. Pharmacol. 2005, 69, 951-960.
5. Hengstschlager, M.; Denk, C.; Wawra, E. Cell cycle regulation of deoxycytidine kinase. Evidence for post-transcriptional control. FEBS Lett. 1993, 321, 237-240.
6. Richel, D.J.; Colly, L.P.; Arentsen-Honders, M.W.; Starrenburg, C.W.; Willemze, R. Deoxycytidine kinase, thymidine kinase and cytidine deaminase and the formation of Ara-CTP in leukemic cells in different phases of the cell cycle. Leuk. Res. 1990, 14, 363-369.
7. Pegoraro, L.; Bernengo, M.G. Thymidine kinase, deoxycytidine kinase and deoxycytidylate deaminase activities in phytohaemagglutinin stimulated human lymphocytes. Exp. Cell Res. 1971, 68, 283-290.
8. Rodriguez, C.O. Jr.; Gandhi, V. Arabinosylguanine-induced apoptosis of T-lymphoblastic cells: incorporation into DNA is a necessary step. Cancer Res. 1999, 59, 4937-4943.
9. Mansson, E.; Flordal, E.M.; Liliemark, J.; Spasokoukotskaja, T.; Elford, H.; Lagercrantz, S.; Eriksson, S.; Albertioni, F. Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance. Biochem. Pharmacol. 2003, 65, 237-247.
10. Lotfi, K.; Mansson, E.; Peterson, C.; Eriksson, S.; Albertioni, F. Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-D-arabinofuranosylguanine cytotoxicity. Biochem. Biophys. Res. Commun. 2002, 293, 1489-1496.